This therapeutic is a humanized antibody specifically targeting MUC1, a glycoprotein frequently overexpressed in various cancers , including pancreatic adenocarcinoma . Its mode of function involves attaching to MUC1, triggering an immune cytotoxic response that causes cancerous cell death. Clin